MARKER THERAPEUTICS, INC. Depreciation
MARKER THERAPEUTICS, INC. (MRKR) reported Depreciation of $800.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-05-15
- MARKER THERAPEUTICS, INC. depreciation for the quarter ending 2023-03-31 was $800.00K, a 33.33% increase year-over-year.
- MARKER THERAPEUTICS, INC. depreciation for the quarter ending 2022-12-31 was -$1.40M, a 380.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. depreciation for the quarter ending 2022-09-30 was $800.00K, a 33.33% increase year-over-year.
- MARKER THERAPEUTICS, INC. depreciation for the quarter ending 2022-06-30 was $600.00K, a 20.00% increase year-over-year.
- MARKER THERAPEUTICS, INC. depreciation for fiscal 2021 was $2.10M, a 320.00% increase from fiscal 2020.
- MARKER THERAPEUTICS, INC. depreciation for fiscal 2020 was $500.00K, a 400.00% increase from fiscal 2019.
- MARKER THERAPEUTICS, INC. depreciation for fiscal 2019 was $100.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed | Depreciation 143 month | Depreciation 146 month | Depreciation 149 month | Depreciation 152 month | Depreciation 155 month | Depreciation 158 month | Depreciation 161 month | Depreciation 164 month | Depreciation 167 month | Depreciation 170 month | Depreciation 173 month | Depreciation 179 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-15 | -$600.00K derived: sum of 2 quarters · filed 2023-05-15 | $200.00K derived: sum of 3 quarters · filed 2023-05-15 | $800.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||||||
| 2022-12-31 | -$1.40M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-15 | -$600.00K derived: sum of 2 quarters · filed 2023-05-15 | $0.00 derived: sum of 3 quarters · filed 2023-05-15 | $600.00K 10-Q · filed 2023-05-15 | $2.80M 10-K · filed 2023-03-22 | |||||||||||||||
| 2022-09-30 | $800.00K 10-Q · filed 2022-11-10 | $1.40M derived: sum of 2 quarters · filed 2022-11-10 | $2.00M 10-Q · filed 2022-11-10 | $2.50M derived: sum of 4 quarters · filed 2023-03-22 | ||||||||||||||||
| 2022-06-30 | $600.00K 10-Q · filed 2022-08-11 | $1.20M 10-Q · filed 2022-08-11 | $1.70M derived: sum of 3 quarters · filed 2023-03-22 | $2.30M derived: sum of 4 quarters · filed 2023-03-22 | ||||||||||||||||
| 2022-03-31 | $600.00K 10-Q · filed 2022-05-13 | $1.10M derived: sum of 2 quarters · filed 2023-03-22 | $1.70M derived: sum of 3 quarters · filed 2023-03-22 | $2.20M derived: sum of 4 quarters · filed 2023-03-22 | ||||||||||||||||
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $1.10M derived: sum of 2 quarters · filed 2023-03-22 | $1.60M derived: sum of 3 quarters · filed 2023-03-22 | $2.10M 10-K · filed 2023-03-22 | ||||||||||||||||
| 2021-09-30 | $600.00K 10-Q · filed 2022-11-10 | $1.10M derived: sum of 2 quarters · filed 2022-11-10 | $1.60M 10-Q · filed 2022-11-10 | $1.80M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||||||
| 2021-06-30 | $500.00K 10-Q · filed 2022-08-11 | $1.00M 10-Q · filed 2022-08-11 | $1.20M derived: sum of 3 quarters · filed 2022-08-11 | $1.30M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||||||
| 2021-03-31 | $500.00K 10-Q · filed 2022-05-13 | $700.00K derived: sum of 2 quarters · filed 2022-05-13 | $800.00K derived: sum of 3 quarters · filed 2022-05-13 | $900.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||||||||||||||
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $300.00K derived: sum of 2 quarters · filed 2022-03-17 | $400.00K derived: sum of 3 quarters · filed 2022-03-17 | $500.00K 10-K · filed 2022-03-17 | ||||||||||||||||
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-10 | $200.00K derived: sum of 2 quarters · filed 2021-11-10 | $300.00K 10-Q · filed 2021-11-10 | $260.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||||||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-10 | $100.00K 10-Q · filed 2021-08-10 | $90.00K 10-Q · filed 2020-08-10 | $160.00K derived: sum of 3 quarters · filed 2021-08-10 | $190.00K derived: sum of 4 quarters · filed 2021-08-10 | |||||||||||||||
| 2020-03-31 | $30.00K 10-Q · filed 2021-05-12 | $60.00K derived: sum of 2 quarters · filed 2021-05-12 | $90.00K derived: sum of 3 quarters · filed 2021-05-12 | $119.00K derived: sum of 4 quarters · filed 2021-05-12 | ||||||||||||||||
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $60.00K derived: sum of 2 quarters · filed 2021-03-09 | $89.00K derived: sum of 3 quarters · filed 2021-03-09 | $100.00K 10-K · filed 2021-03-09 | $105.00K 10-K · filed 2020-03-12 | |||||||||||||||
| 2019-09-30 | $30.00K 10-Q · filed 2020-11-09 | $31.00K 10-Q · filed 2019-11-12 | $59.00K derived: sum of 2 quarters · filed 2020-11-09 | $70.00K 10-Q · filed 2020-11-09 | $71.00K 10-Q · filed 2019-11-12 | |||||||||||||||
| 2019-06-30 | $29.00K 10-Q · filed 2019-08-09 | $40.00K 10-Q · filed 2020-08-10 | ||||||||||||||||||
| 2019-03-31 | $11.00K 10-Q · filed 2019-05-10 | |||||||||||||||||||
| 2018-12-31 | $0.00 10-Q · filed 2019-11-12 | |||||||||||||||||||
| 2014-06-30 | $213.23K 10-Q · filed 2014-08-18 | |||||||||||||||||||
| 2013-12-31 | $213.23K 10-Q/A · filed 2014-05-21 | |||||||||||||||||||
| 2013-09-30 | $213.23K 10-Q · filed 2013-11-19 | |||||||||||||||||||
| 2013-06-30 | $213.23K 10-Q · filed 2013-08-19 | |||||||||||||||||||
| 2013-03-31 | $213.23K 10-Q/A · filed 2013-08-19 | |||||||||||||||||||
| 2012-12-31 | $213.23K 10-K · filed 2013-05-15 | |||||||||||||||||||
| 2012-09-30 | $213.23K 10-Q · filed 2012-11-19 | |||||||||||||||||||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $213.23K 10-Q/A · filed 2012-09-12 | |||||||||||||||||
| 2012-03-31 | $213.23K 10-Q · filed 2012-05-21 | |||||||||||||||||||
| 2011-12-31 | $213.23K 10-K · filed 2012-04-16 | |||||||||||||||||||
| 2011-09-30 | $213.23K 10-Q · filed 2011-11-21 | |||||||||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-12 | $0.00 10-Q/A · filed 2012-09-12 | $213.23K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |